Still, the generic competition could cause Vascepa sales to erode between 6% to 22% by 2023, Leerink estimated. The analysts said that erosion could be lessened if Amarin’s new strategy works ...

Explore leading players in the generic drug pharmaceutical industry and why their diversification strategies are poising them for growth. Download now.

Here are four ways Dr. Gottlieb seeks to address high drug costs. 1. Increase generic competition. Dr. Gottlieb told Bloomberg the FDA is exploring how to prioritize the review of applications for ...

Replacing the combination of brand-name, antiretroviral drugs currently recommended for control of HIV infection with soon-to-be-available generic medications could save the U.S. health care ...